Cumin extract
CAS 84775-51-9
Cumin extract (CAS 84775-51-9) is a pharmaceutical compound with 0 bioactivity targets and 21 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Cumin extract is linked to DTXSID401018347 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Cumin extract used for in pharmaceutical contexts?
Cumin extract (CAS 84775-51-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Cumin extract?
Cumin extract has 21 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal pain lower, Alanine aminotransferase increased, Animal bite, Arthralgia, Aspartate aminotransferase increased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Cumin extract also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Cuminum Cyminum Fruit Extract with EU status "restricted".
What clinical phase is Cumin extract in?
No phase 1-4 clinical development badge is rendered for Cumin extract because the matched compound identifier rows do not contain a max-phase value.